These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies. Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960 [TBL] [Abstract][Full Text] [Related]
9. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies. Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646 [TBL] [Abstract][Full Text] [Related]
10. Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7. Chohan TA; Qian HY; Pan YL; Chen JZ Mol Biosyst; 2016 Jan; 12(1):145-61. PubMed ID: 26565382 [TBL] [Abstract][Full Text] [Related]
11. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors. Tripathi SK; Muttineni R; Singh SK J Theor Biol; 2013 Oct; 334():87-100. PubMed ID: 23727278 [TBL] [Abstract][Full Text] [Related]
12. Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors. Zhang G; Ren Y Molecules; 2018 Nov; 23(11):. PubMed ID: 30423939 [TBL] [Abstract][Full Text] [Related]
13. A study on MAPK/ERK and CDK2-Cyclin-E signal switch "on and off" in cell proliferation by bis urea derivatives of 1, 4-Diisocyanatobenzene. Nagalakshmamma V; Venkataswamy M; Pasala C; Uma Maheswari A; Thyaga Raju K; Nagaraju C; Chalapathi PV Bioorg Chem; 2021 Jul; 112():104940. PubMed ID: 33965780 [TBL] [Abstract][Full Text] [Related]
14. Virtual screening, molecular docking, MD simulation studies, DFT calculations, ADMET, and drug likeness of Diaza-adamantane as potential MAPK Gheidari D; Mehrdad M; Hoseini F Front Pharmacol; 2024; 15():1360226. PubMed ID: 39021828 [No Abstract] [Full Text] [Related]
15. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations. Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817 [TBL] [Abstract][Full Text] [Related]
17. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity. Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976 [TBL] [Abstract][Full Text] [Related]
18. 5-Oxo-dihydropyranopyran derivatives as anti-proliferative agents; synthesis, biological evaluation, molecular docking, MD simulation, DFT, and Ranjbar S; Sadeghian P; Khademian S; Emami M; Jahromi ZP; Mirmajidi SH; Zare F; Negahdaripour M; Ghasemi Y; Khoshneviszadeh M Heliyon; 2024 May; 10(9):e29850. PubMed ID: 38707385 [TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics and QM/MM-based 3D interaction analyses of cyclin-E inhibitors. Pasha FA; Neaz MM J Mol Model; 2013 Feb; 19(2):879-91. PubMed ID: 23086460 [TBL] [Abstract][Full Text] [Related]
20. The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches. Li HL; Ma Y; Ma Y; Li Y; Chen XB; Dong WL; Wang RL Oncotarget; 2017 May; 8(20):33225-33240. PubMed ID: 28402259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]